DZ Bank Reiterates “Neutral” Rating for Gerresheimer (ETR:GXI)

DZ Bank reaffirmed their neutral rating on shares of Gerresheimer (ETR:GXI) in a research report report published on Thursday, Borsen Zeitung reports.

Several other equities research analysts have also recently weighed in on the company. Deutsche Bank decreased their target price on from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating for the company in a research note on Monday, June 24th. Kepler Capital Markets set a €19.00 ($22.09) target price on Rhoen Klinikum and gave the stock a sell rating in a research note on Thursday, April 11th. Credit Suisse Group restated a hold rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Independent Research set a €72.00 ($83.72) target price on Gerresheimer and gave the stock a neutral rating in a research note on Friday, April 12th. Finally, Goldman Sachs Group upgraded Altria Group from a neutral rating to a buy rating and set a $59.00 target price for the company in a research note on Thursday. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of €69.17 ($80.43).

GXI stock opened at €73.65 ($85.64) on Thursday. The stock’s 50 day simple moving average is €65.08. The stock has a market capitalization of $2.31 billion and a PE ratio of 12.90. Gerresheimer has a fifty-two week low of €51.10 ($59.42) and a fifty-two week high of €80.25 ($93.31). The company has a debt-to-equity ratio of 68.19, a quick ratio of 0.51 and a current ratio of 0.78.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: The mechanics of the bid-ask spread in trading

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.